438 related articles for article (PubMed ID: 33078696)
1. Methylene blue is a potent and broad-spectrum inhibitor against Zika virus
Li Z; Lang Y; Sakamuru S; Samrat S; Trudeau N; Kuo L; Rugenstein N; Tharappel A; D'Brant L; Koetzner CA; Hu S; Zhang J; Huang R; Kramer LD; Butler D; Xia M; Li H
Emerg Microbes Infect; 2020 Dec; 9(1):2404-2416. PubMed ID: 33078696
[TBL] [Abstract][Full Text] [Related]
2. Erythrosin B is a potent and broad-spectrum orthosteric inhibitor of the flavivirus NS2B-NS3 protease.
Li Z; Sakamuru S; Huang R; Brecher M; Koetzner CA; Zhang J; Chen H; Qin CF; Zhang QY; Zhou J; Kramer LD; Xia M; Li H
Antiviral Res; 2018 Feb; 150():217-225. PubMed ID: 29288700
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the Zika virus two-component NS2B-NS3 protease and structure-assisted identification of allosteric small-molecule antagonists.
Shiryaev SA; Farhy C; Pinto A; Huang CT; Simonetti N; Elong Ngono A; Dewing A; Shresta S; Pinkerton AB; Cieplak P; Strongin AY; Terskikh AV
Antiviral Res; 2017 Jul; 143():218-229. PubMed ID: 28461069
[TBL] [Abstract][Full Text] [Related]
4. The Inhibition of NS2B/NS3 Protease: A New Therapeutic Opportunity to Treat Dengue and Zika Virus Infection.
Starvaggi J; Previti S; Zappalà M; Ettari R
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673962
[TBL] [Abstract][Full Text] [Related]
5. Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo.
Yuan S; Chan JF; den-Haan H; Chik KK; Zhang AJ; Chan CC; Poon VK; Yip CC; Mak WW; Zhu Z; Zou Z; Tee KM; Cai JP; Chan KH; de la Peña J; Pérez-Sánchez H; Cerón-Carrasco JP; Yuen KY
Antiviral Res; 2017 Sep; 145():33-43. PubMed ID: 28712942
[TBL] [Abstract][Full Text] [Related]
6. An Antiviral Peptide from
Ji M; Zhu T; Xing M; Luan N; Mwangi J; Yan X; Mo G; Rong M; Li B; Lai R; Jin L
Toxins (Basel); 2019 Oct; 11(10):. PubMed ID: 31658707
[TBL] [Abstract][Full Text] [Related]
7. Discovery, X-ray Crystallography and Antiviral Activity of Allosteric Inhibitors of Flavivirus NS2B-NS3 Protease.
Yao Y; Huo T; Lin YL; Nie S; Wu F; Hua Y; Wu J; Kneubehl AR; Vogt MB; Rico-Hesse R; Song Y
J Am Chem Soc; 2019 May; 141(17):6832-6836. PubMed ID: 31017399
[TBL] [Abstract][Full Text] [Related]
8. SAR evolution towards potent C-terminal carboxamide peptide inhibitors of Zika virus NS2B-NS3 protease.
Colarusso S; Ferrigno F; Ponzi S; Pavone F; Conte I; Abate L; Beghetto E; Missineo A; Amaudrut J; Bresciani A; Paonessa G; Tomei L; Montalbetti C; Bianchi E; Toniatti C; Ontoria JM
Bioorg Med Chem; 2022 Mar; 57():116631. PubMed ID: 35123179
[TBL] [Abstract][Full Text] [Related]
9. Cell-active carbazole derivatives as inhibitors of the zika virus protease.
Rassias G; Zogali V; Swarbrick CMD; Ki Chan KW; Chan SA; Gwee CP; Wang S; Kaplanai E; Canko A; Kiousis D; Lescar J; Luo D; Matsoukas MT; Vasudevan SG
Eur J Med Chem; 2019 Oct; 180():536-545. PubMed ID: 31344613
[TBL] [Abstract][Full Text] [Related]
10. Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction.
Li Z; Brecher M; Deng YQ; Zhang J; Sakamuru S; Liu B; Huang R; Koetzner CA; Allen CA; Jones SA; Chen H; Zhang NN; Tian M; Gao F; Lin Q; Banavali N; Zhou J; Boles N; Xia M; Kramer LD; Qin CF; Li H
Cell Res; 2017 Aug; 27(8):1046-1064. PubMed ID: 28685770
[TBL] [Abstract][Full Text] [Related]
11. Proline-Based Allosteric Inhibitors of Zika and Dengue Virus NS2B/NS3 Proteases.
Millies B; von Hammerstein F; Gellert A; Hammerschmidt S; Barthels F; Göppel U; Immerheiser M; Elgner F; Jung N; Basic M; Kersten C; Kiefer W; Bodem J; Hildt E; Windbergs M; Hellmich UA; Schirmeister T
J Med Chem; 2019 Dec; 62(24):11359-11382. PubMed ID: 31769670
[TBL] [Abstract][Full Text] [Related]
12. Potential Role of Flavivirus NS2B-NS3 Proteases in Viral Pathogenesis and Anti-flavivirus Drug Discovery Employing Animal Cells and Models: A Review.
Wahaab A; Mustafa BE; Hameed M; Stevenson NJ; Anwar MN; Liu K; Wei J; Qiu Y; Ma Z
Viruses; 2021 Dec; 14(1):. PubMed ID: 35062249
[TBL] [Abstract][Full Text] [Related]
13. NS2B-NS3 protease inhibitors as promising compounds in the development of antivirals against Zika virus: A systematic review.
Nunes DAF; Santos FRDS; da Fonseca STD; de Lima WG; Nizer WSDC; Ferreira JMS; de Magalhães JC
J Med Virol; 2022 Feb; 94(2):442-453. PubMed ID: 34636434
[TBL] [Abstract][Full Text] [Related]
14. Viperin Restricts Zika Virus and Tick-Borne Encephalitis Virus Replication by Targeting NS3 for Proteasomal Degradation.
Panayiotou C; Lindqvist R; Kurhade C; Vonderstein K; Pasto J; Edlund K; Upadhyay AS; Överby AK
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321318
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, Structure-Activity Relationships, and Antiviral Activity of Allosteric Inhibitors of Flavivirus NS2B-NS3 Protease.
Nie S; Yao Y; Wu F; Wu X; Zhao J; Hua Y; Wu J; Huo T; Lin YL; Kneubehl AR; Vogt MB; Ferreon J; Rico-Hesse R; Song Y
J Med Chem; 2021 Mar; 64(5):2777-2800. PubMed ID: 33596380
[TBL] [Abstract][Full Text] [Related]
16. Exploiting the unique features of Zika and Dengue proteases for inhibitor design.
Majerová T; Novotný P; Krýsová E; Konvalinka J
Biochimie; 2019 Nov; 166():132-141. PubMed ID: 31077760
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory Compound Shows Therapeutic Safety and Efficacy against Flavivirus Infection.
Chuang FK; Huang SM; Liao CL; Lee AR; Lien SP; Chiu YL; Chang TH; Tsai PL; Lin RJ; Shih CC; Tsai YJ; Lin GJ; Yen LC
Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31636070
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, structure-activity relationship and antiviral activity of indole-containing inhibitors of Flavivirus NS2B-NS3 protease.
Nie S; Zhao J; Wu X; Yao Y; Wu F; Lin YL; Li X; Kneubehl AR; Vogt MB; Rico-Hesse R; Song Y
Eur J Med Chem; 2021 Dec; 225():113767. PubMed ID: 34450494
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationship of flavonoid bifunctional inhibitors against Zika virus infection.
Zou M; Liu H; Li J; Yao X; Chen Y; Ke C; Liu S
Biochem Pharmacol; 2020 Jul; 177():113962. PubMed ID: 32272109
[TBL] [Abstract][Full Text] [Related]
20. Antiviral activity of the natural alkaloid anisomycin against dengue and Zika viruses.
Quintana VM; Selisko B; Brunetti JE; Eydoux C; Guillemot JC; Canard B; Damonte EB; Julander JG; Castilla V
Antiviral Res; 2020 Apr; 176():104749. PubMed ID: 32081740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
